This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fukuhara, K. Articles by Fujii, S. Search for Related Content PubMed PubMed Citation Articles by Fukuhara, K. Articles by Fujii, S. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM Protein UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB ESTRADIOL PROGESTERONE Medline Plus Health Information Uterine Cancer Uterine Fibroids

Secreted Frizzled Related Protein 1 Is Overexpressed in Uterine Leiomyomas, Associated with a High Estrogenic Environment and Unrelated to Proliferative Activity

Departments of Gynecology and Obstetrics (K.F., M.Ka., M.Ki., H.S., T.K., C.K., A.O., S.F.) and Clinical Molecular Biology (K.F., J.F.), Faculty of Medicine, Kyoto University, Sakyoku, Kyoto 606-8507, Japan

Address all correspondence and requests for reprints to: Shingo Fujii, M.D., Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Sakyoku, Kyoto 606-8507, Japan. E-mail: . sfu{at}kuhp kyoto-u.ac.jp

Abstract

Secreted frizzled related protein 1 (sFRP1) is a modulator of Wnt signaling. Recently, aberrations of Wnt signaling were reported to be involved in the pathology of various human neoplasms. We investigated the expression and function of sFRP1 in uterine leiomyomas. Secreted FRP1 expression was increased in leiomyomas, compared with normal myometrium using Northern and Western blot analyses. Expression was strongest in the late follicular phase (high estrogenic milieu) of the menstrual cycle. Interestingly, expression was negligible in leiomyomas treated with GnRH agonist. Expression was also prominent in cells during E2 treatment, serum deprivation, and hypoxia. Moreover, induction of apoptosis by serum deprivation in a leiomyosarcoma cell line was enhanced by antisense inhibition of sFRP1. These results suggest that sFRP1 expression was associated with uterine leiomyomas, particularly under high estrogenic conditions. Secreted FRP1 expression was not associated with cell proliferation but rather occurred during cell protection against apoptosis in vitro. Strong sFRP1 expression under high estrogenic conditions seems to contribute to the development of uterine leiomyomas through the antiapoptotic effect of sFRP1, which appear to be independent of cell proliferation.

This article has been cited by other articles:

				M. Koler, H. Achache, A. Tsafrir, Y. Smith, A. Revel, and R. Reich Disrupted gene pattern in patients with repeated in vitro fertilization (IVF) failure Hum. Reprod., October 1, 2009; 24(10): 2541 - 2548. [Abstract] [Full Text] [PDF]

				S. Saini, J. Liu, S. Yamamura, S. Majid, K. Kawakami, H. Hirata, and R. Dahiya Functional Significance of Secreted Frizzled-Related Protein 1 in Metastatic Renal Cell Carcinomas Cancer Res., September 1, 2009; 69(17): 6815 - 6822. [Abstract] [Full Text] [PDF]

				M. Ono, T. Maruyama, H. Masuda, T. Kajitani, T. Nagashima, T. Arase, M. Ito, K. Ohta, H. Uchida, H. Asada, et al. Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells PNAS, November 20, 2007; 104(47): 18700 - 18705. [Abstract] [Full Text] [PDF]

				M. L. Gumz, H. Zou, P. A. Kreinest, A. C. Childs, L. S. Belmonte, S. N. LeGrand, K. J. Wu, B. A. Luxon, M. Sinha, A. S. Parker, et al. Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell Carcinoma Clin. Cancer Res., August 15, 2007; 13(16): 4740 - 4749. [Abstract] [Full Text] [PDF]

				M. Breuiller-Fouche and G. Germain Gene and protein expression in the myometrium in pregnancy and labor. Reproduction, May 1, 2006; 131(5): 837 - 850. [Abstract] [Full Text] [PDF]

				M. S. Joesting, S. Perrin, B. Elenbaas, S. E. Fawell, J. S. Rubin, O. E. Franco, S. W. Hayward, G. R. Cunha, and P. C. Marker Identification of SFRP1 as a Candidate Mediator of Stromal-to-Epithelial Signaling in Prostate Cancer Cancer Res., November 15, 2005; 65(22): 10423 - 10430. [Abstract] [Full Text] [PDF]

				S. Mangioni, P. Vigano, D. Lattuada, A. Abbiati, M. Vignali, and A. M. Di Blasio Overexpression of the Wnt5b Gene in Leiomyoma Cells: Implications for a Role of the Wnt Signaling Pathway in the Uterine Benign Tumor J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5349 - 5355. [Abstract] [Full Text] [PDF]

				C.J. Loy, S. Evelyn, F.K. Lim, M.H. Liu, and E.L. Yong Growth dynamics of human leiomyoma cells and inhibitory effects of the peroxisome proliferator-activated receptor-{gamma} ligand, pioglitazone Mol. Hum. Reprod., August 1, 2005; 11(8): 561 - 566. [Abstract] [Full Text] [PDF]

				X. Luo, L. Ding, J. Xu, R. S. Williams, and N. Chegini Leiomyoma and Myometrial Gene Expression Profiles and Their Responses to Gonadotropin-Releasing Hormone Analog Therapy Endocrinology, March 1, 2005; 146(3): 1074 - 1096. [Abstract] [Full Text] [PDF]

				T. Kanamori, K. Takakura, M. Mandai, M. Kariya, K. Fukuhara, M. Sakaguchi, N.-h. Huh, K. Saito, T. Sakurai, J. Fujita, et al. Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours Mol. Hum. Reprod., October 1, 2004; 10(10): 735 - 742. [Abstract] [Full Text] [PDF]

				C.E. Hoei-Hansen, J.E. Nielsen, K. Almstrup, M.A. Hansen, N.E. Skakkebaek, E. Rajpert-DeMeyts, and H. Leffers Identification of genes differentially expressed in testes containing carcinoma in situ Mol. Hum. Reprod., June 1, 2004; 10(6): 423 - 431. [Abstract] [Full Text] [PDF]

				X. Han and S. Amar Secreted Frizzled-related Protein 1 (SFRP1) Protects Fibroblasts from Ceramide-induced Apoptosis J. Biol. Chem., January 23, 2004; 279(4): 2832 - 2840. [Abstract] [Full Text] [PDF]

				K. Politi, M. Szabolcs, P. Fisher, A. Kljuic, T. Ludwig, and A. Efstratiadis A Mouse Model of Uterine Leiomyosarcoma Am. J. Pathol., January 1, 2004; 164(1): 325 - 336. [Abstract] [Full Text] [PDF]

				K. S. Rehman, S. Yin, B. A. Mayhew, R.A. Word, and W. E. Rainey Human myometrial adaptation to pregnancy: cDNA microarray gene expression profiling of myometrium from non-pregnant and pregnant women Mol. Hum. Reprod., November 1, 2003; 9(11): 681 - 700. [Abstract] [Full Text] [PDF]

				T. Kanamori, K. Takakura, M. Mandai, M. Kariya, K. Fukuhara, T. Kusakari, C. Momma, H. Shime, H. Yagi, M. Konishi, et al. PEP-19 overexpression in human uterine leiomyoma Mol. Hum. Reprod., November 1, 2003; 9(11): 709 - 717. [Abstract] [Full Text] [PDF]

				N. Chegini, J. Verala, X. Luo, J. Xu, and R. S. Williams Gene Expression Profile of Leiomyoma and Myometrium and the Effect of Gonadotropin Releasing Hormone Analogue Therapy Reproductive Sciences, April 1, 2003; 10(3): 161 - 171. [Abstract] [PDF]